Treatment adequacy of anxiety disorders among young adults in Finland

Show full item record



Permalink

http://hdl.handle.net/10138/161349

Citation

Kasteenpohja , T , Marttunen , M , Aalto-Setala , T , Perälä , J , Saarni , S I & Suvisaari , J 2016 , ' Treatment adequacy of anxiety disorders among young adults in Finland ' , BMC Psychiatry , vol. 16 , 63 . https://doi.org/10.1186/s12888-016-0766-0

Title: Treatment adequacy of anxiety disorders among young adults in Finland
Author: Kasteenpohja, Teija; Marttunen, Mauri; Aalto-Setala, Terhi; Perälä, Jonna; Saarni, Samuli I.; Suvisaari, Jaana
Contributor: University of Helsinki, Clinicum
University of Helsinki, Clinicum
University of Helsinki, Department of Psychiatry
Date: 2016-03-15
Language: eng
Number of pages: 13
Belongs to series: BMC Psychiatry
ISSN: 1471-244X
URI: http://hdl.handle.net/10138/161349
Abstract: Background: Anxiety disorders are common in early adulthood, but general population studies concerning the treatment adequacy of anxiety disorders taking into account appropriate pharmacological and psychological treatment are scarce. The aims of this study were to examine treatments received for anxiety disorders in a Finnish general population sample of young adults, and to define factors associated with receiving minimally adequate treatment and with dropping out from treatment. Methods: A questionnaire containing several mental health screens was sent to a nationally representative two-stage cluster sample of 1894 Finns aged 19 to 34 years. All screen positives and a random sample of screen negatives were invited to a mental health assessment including a SCID interview. For the final diagnostic assessment, case records from mental health treatments for the same sample were obtained. This article investigates treatment received, treatment adequacy and dropouts from treatment of 79 participants with a lifetime anxiety disorder (excluding those with a single specific phobia). Based on all available information, receiving antidepressant or buspirone medication for at least 2 months with at least four visits with any type of physician or at least eight sessions of psychotherapy within 12 months or at least 4 days of hospitalization were regarded as minimally adequate treatment for anxiety disorders. Treatment dropout was rated if the patient discontinued the visits by his own decision despite having an adequate treatment strategy according to the case records. Results: Of participants with anxiety disorders (excluding those with a single specific phobia), 41.8 % had received minimally adequate treatment. In the multivariate analysis, comorbid substance use disorder was associated with antidepressant or buspirone medication lasting at least 2 months. Those who were currently married or cohabiting had lower odds of having at least four visits with a physician a year. None of these factors were associated with the final outcome of minimally adequate treatment or treatment dropout. Participants with comorbid personality disorders received and misused benzodiazepines more often than others. Conclusions: More efforts are needed to provide adequate treatment for young adults with anxiety disorders. Attention should be paid to benzodiazepine prescribing to individuals with personality disorders.
Subject: Anxiety disorders
Epidemiology
Quality of care
Young adults
COMORBIDITY SURVEY REPLICATION
FINNISH GENERAL-POPULATION
MENTAL-HEALTH TREATMENT
OF-ONSET DISTRIBUTIONS
PRIMARY-CARE PATIENTS
DSM-IV DISORDERS
PSYCHIATRIC-DISORDERS
DEPRESSIVE-DISORDERS
LIFETIME PREVALENCE
UNITED-STATES
3124 Neurology and psychiatry
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
s12888_016_0766_0.pdf 476.9Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record